Search

everythinglearnresearchcommunity

for

Search:↓

Tattooing improves appearance of scalp alopecia and scars.

Herbal hair oil made from herbs and coconut oil helps reduce dandruff and hair fall.

No single biomarker is reliable enough for diagnosing and assessing SLE.

Polycystic Ovarian Syndrome is common in overweight urban college girls and may increase the risk of heart and metabolic problems.

Clinical exams are good for diagnosing some women's hair loss, but lab tests aren't always needed.

Effective treatment for midlife women's hair loss is limited, with 5% minoxidil foam being the only proven option for the most common type.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

Treating psoriasis with UVB light three times a week is faster than twice a week, and certain medications and lifestyle factors affect psoriasis treatment outcomes.

The document concludes that various treatments for skin conditions are effective, but some require further research, and certain factors like gender and lifestyle can influence disease outcomes.

Most people who volunteered for a health study had medical issues, showing the need for careful screening before trials.

Patients need long-term care after bariatric surgery to manage potential nutritional and metabolic issues.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

Correcting nutrient deficiencies may help with hair loss, but the benefits of supplements without a deficiency are uncertain and could be harmful.

Certain groups may need vitamin supplements to improve hair health and prevent other health problems.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

The document concludes that using specific tools and tests is essential for identifying the cause of hair loss and deciding on the right treatment.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Ultraviolet rays damage hair, smoking may cause hair loss, and good nutrition is important for hair health, but genetics mainly decide hair thickness.

The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.

Patients with chronic renal failure on hemodialysis often have skin problems like dry skin, itching, and nail changes.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

ATE is linked to FAA, and treatment depends on cause; minoxidil helps, finasteride may worsen.

Adjuvants, diet changes, and laser therapy may improve male pattern hair loss.

The document concludes that scalp disorders can be treated with hair washing, specific shampoos, medications, and sometimes surgery or hair transplants, but hereditary baldness is untreatable.

Up to 50% of scalp hair can be lost before it appears thin, and treatment is only needed for hair loss caused by diseases or deficiencies.

Iron deficiency anemia may contribute to hair loss in women with Telogen effluvium.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.